Who are we?

Better brain care

Our mission


It is only with the heart that one can see rightly; what is essential is invisible to the eyes.

It is only with Braintale that one can see rightly, what is essential is invisible to the eyes.

Who are we?

BrainTale is an innovative company opening a new era in medicine. We aim at providing physicians with clinically validated diagnostic, monitoring and prognostic solutions for the management of brain injured patients through sensitive and reliable measurements of white-matter microstructure alterations. Building on more than 15 years of clinical development, BrainTale’s products are developed collaboratively to address medical need and fulfil expectations of healthcare professionals and patients alike.

Our team is composed of experienced, passionate and committed professionals. We are eager to deliver and to make the difference. In daily contact with patients, our approach is concrete, humanistic and realistic at the service of health.

Our Values

Engagement and passion

Science excellence


Fulfilling medical needs

Patient benefit centric

Executive Team

 Julie Rachline

Co-founder & CEO

Vincent Perlbarg

Co-founder, President & Chief Scientific Officer

Jean-Baptiste Martini

Chief Technology Officer

Thierry Mignot

Chief Financial and Administrative Officer

Florence Kocher

Chief Business Officer

Strategic board

Pr. Spyros Artavanis-Tsakonas

Dr. Nitza Thomasson

Pr. Eric Garnier

Sébastien Couvet

Virginie Miath

Vincent Perlbarg

 Julie Rachline

Scientific advisors

Dr. Louis Puybasset

Dr. Lionel Velly

Dr. Rajiv Gupta

Dr. Damien Galanaud

Dr. Pierre-François Pradat

Dr. Fanny Mochel

BRAINTALE, whose head office is 11 rue de l’Académie 67000 – STRASBOURG, is registered in the Trade and Companies Register under number 840 995 138 RCS STRASBOURG

Last update : 30/05/2023